Phase I Trial of Radiochemotherapy with Bendamustine in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
β Scribed by Dirk Bottke; Kathrin Bathe; Thomas Wiegel; Wolfgang Hinkelbein
- Book ID
- 105776467
- Publisher
- Springer
- Year
- 2007
- Tongue
- German
- Weight
- 274 KB
- Volume
- 183
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Fortyβtwo patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv
## Abstract ## Background We have shown that rILβ2 administration in recurrent head and neck cancers induces a tumorβspecific Tβlymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5βfluorouracil. Longβterm results
## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the